HOME > ARCHIVE
ARCHIVE
- Yamanouchi: Record Sales Boost Domestic Share to 5%
June 2, 2003
- Fukujin Wants to Become No. 1 Drug Wholesaler by Merging with Azwell
June 2, 2003
- Shionogi: Restructuring Affects Sales, Net Profits
June 2, 2003
- Pfizer to Introduce 8-Sector, 13-Team System: President Bootes
June 2, 2003
- Chugai: Merger Drives It to 4th Position in Japan
June 2, 2003
- Purdue to Market Meiji Seika's Meiact in North America
June 2, 2003
- Banyu: Nu-lotan Drives Sales to \185.4 Bil.
June 2, 2003
- Over 40% of Leading Makers Hired Over 100 New Employees in April: Survey
June 2, 2003
- Annual Business Results
May 26, 2003
- Fewer Children for 22nd Year in a Row: Somusho Statistics
May 26, 2003
- Annual Business Results
May 26, 2003
- REGULATORY NEWS IN BRIEF
May 26, 2003
- Annual Business Results
May 26, 2003
- 50th Anniversary of DNA Discovery Celebrated
May 26, 2003
- Shoda Appointed President of Sankyo
May 26, 2003
- Annual Business Results
May 26, 2003
- RESEARCH &DEVELOPMENT NEWS IN BRIEF
May 26, 2003
- BULLETIN
May 26, 2003
- Annual Business Results
May 26, 2003
- OTC NEWS IN BRIEF
May 26, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
